In conclusion, enhancing Nrf2 efficacy represents a promising therapeutic strategy to counteract mitochondrial dysfunction, oxidative stress, and neurodegeneration in ALS, C9orf72-related diseases, and other neurodegenerative conditions. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.